MedPath

QIST Collaborative - Arthroplasty Research Cohort (ARC) Study

Recruiting
Conditions
Hip Arthritis
Knee Arthritis
Registration Number
NCT05824845
Lead Sponsor
Northumbria Healthcare NHS Foundation Trust
Brief Summary

The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives:

1. To evaluate outcomes following hip and knee replacements.

2. To determine risk factors for adverse outcomes in primary hip and knee replacements.

3. To identify targets for future research and intervention in patients undergoing primary hip and knee replacements

4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in the ARC Study as comparison or control data for trial participants who have been randomised to receive one or more interventions.

Participants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting list, in addition to an advertising campaign to recruit patients. They are directed to an online portal where they will be able to review further information.

Consent and data collection is completed electronically through patients entering data online. Baseline demographics and characteristics are recorded, including details of socio-demographics, lifestyle, health status and patient reported outcome measures (PROMs). Patients then undergo hip/knee replacement and postoperative rehabilitation according to the standard care and protocols of the hospital and the preferences of their treating surgeon.

Follow-up data, including PROMs, is collected via online questionnaires up to two years following surgery. The study will ultimately also enable multiple trials to be embedded within the cohort study, using a 'Trials within Cohorts' (TwiCs) methodology.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria

Participants must meet all of the inclusion criteria:

  1. UK Resident
  2. Able to read and understand documentation and questionnaires in English language
  3. Undergoing elective primary hip or knee arthroplasty (THR, TKR or UKR)
  4. Age 18 years or over
  5. Provides the necessary consents relating to data collection and use of study data, data linkage, future research and invitation to involvement in future trials
Exclusion Criteria

Provided a participant meets all of the inclusion criteria, there are no exclusion criteria for the cohort study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EQ-5D-5L health-related quality of life score2 years
Secondary Outcome Measures
NameTimeMethod
PROMIS-102 years

Patient-Reported Outcomes Measurement Information System Global Health

Oxford Hip Score2 years
Oxford Knee Score2 years
Pain Catastrophising Scale2 years
Activity2 years

Levels of exercise and activity self-reported by study specific electronic questionnaire

Surgical Site Infection2 years
Patient Health Questionnaire-42 years

PHQ-4

Musculoskeletal Health Questionnaire2 years

MSK-HQ

Hospital for Special Surgery Hip/Knee Replacement Expectations Surveys2 years

Perception of success/fulfilment of expectations

11-point Numerical Pain Rating Scale2 years

Pain

Readmission within 30 days30 days
Dislocation2 years
Revision/Re-operation2 years
Length of stay2 years

Self-reported by study specific electronic questionnaire

Return to work2 years

Work status self-reported by electronic questionnaire using National Statistics Socio-economic Classification

Periprosthetic Fracture2 years
Mortality2 years

Trial Locations

Locations (1)

Northumbria Healthcare NHS Foundation Trust

🇬🇧

Ashington, United Kingdom

Northumbria Healthcare NHS Foundation Trust
🇬🇧Ashington, United Kingdom
William Fishley
Contact
01912934087
arcstudy@northumbria-healthcare.nhs.uk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.